Interaction Between Spasticity and the Initial Response After Balance Perturbations in Children With Spastic Cerebral Palsy
Association Between the Initial Response After Perturbation to Standing Balance and Spasticity Measurements (1) and Kinematic Response Strategy to Restore Balance (2) in Children With Spastic Cerebral Palsy
調査の概要
詳細な説明
Background:
Spasticity is a common impairment following an upper motor neuron lesion, such as cerebral palsy (CP). Children with CP suffer a lot from balance impairments, which will impair their participation in daily life activities. When clinically assessing spasticity, a passive muscle is stretched and spasticity is scored based on the observed resistance against this stretch. Similar muscle stretches also occur when standing balance is perturbed, as for example when standing on a departing bus or walking on uneven terrain.
Maintaining balance involves complex sensorimotor transformations to activate the muscle to produce the required balance correcting response. Sensorimotor processing refers to how the nervous system translates incoming sensory information about body motion into motor commands to activate muscles. In both healthy animals and humans, sensorimotor processes underlying reactive standing balance can be explained by delayed feedback from CoM kinematics. The sensitivity to the CoM disturbance have been shown to be relatively constant within one subject, but change with age, age-related cognitive decline, sensory deficits, and neurological impairments.
Both kinematic and muscle responses to perturbations of standing balance are impaired in children with CP. Children with CP have a higher chance of losing their balance, change to a stepping strategy at lower perturbation levels, and have increased muscle (co-)activation. However, it is unknown whether the underlying sensorimotor transformations are altered in CP and how these changes contribute to the altered balance responses observed in CP. Therefore, the first aim was to understand alterations in sensorimotor processing underlying reactive standing balance control in children with spastic CP.
The increased muscle co-activation that is observed in CP might be a functional compensation strategy to improve balance control. For example, muscle co-activation will increase joint stiffness and therefore resisting movement of the body with respect to the feet during backward translational perturbations. In this case, co-activation will help to maintain balance. However, it is not clear whether children with CP use the increased co-activation as compensation strategy to improve balance control or whether the muscle co-activation is a consequence of impaired balance control. When standing balance is perturbed using rotational perturbations, muscle co-activation will hinder balance control. Increased muscle co-activation and the following increased joint stiffness will couple body movement to platform movement resulting in body tilt. Hence, increasing joint stiffness might not be beneficial during rotational perturbations. Our second aim was to investigate whether children with CP use increased muscle co-activation as a compensation strategy to improve balance control or whether muscle co-activation causes balance control impairments by combining translational and rotational perturbations of standing balance.
Muscle stretches occur during isolated joint rotations, as clinically applied when assessing joint hyper-resistance, and during perturbations of standing balance. Children with CP respond to both isolated joint rotations and perturbations of standing with increased excitation of the stretched muscle, combined with increased agonist-antagonist co-activation. Although the striking similarities between both reactive muscle responses to muscle stretches, little is known about the relation between joint hyper-resistance and reactive balance. Therefore our third aim was to explore the relation between muscle responses to instrumented tests of joint hyper-resistance and translational and rotational perturbations of standing balance.
Methods:
Twenty children with CP and twenty age-matched typically developing (TD) children participated in this study. Children with CP were diagnosed by a neuro-pediatrician and met the following inclusion criteria: (1)aged between 5 and 17 years old; (32) Gross Motor Classification Scale I-III; (3) able to stand independently for at least 10 minutes; (4) no orthopedic/neurological surgery in the previous year; and (5) no botulinum neurotoxin injections in the previous six months.
An instrumented spasticity assessment (hereafter called isolated joint rotations) using the method described by Bar-On and colleagues was performed. Participants lay supine and were asked to relax. The lower leg was supported by a customized frame that allowed ankle rotation. A researcher applied five times a passive rotation of the ankle joint, as fast as possible from a plantar flexed position to the end range of motion towards dorsiflexion.
Reactive balance was tested on a Caren platform. Participants stood barefoot on the platform and were secured with a safety harness. Instructions were to stand upright and maintain balance without stepping unless stepping was necessary to avoid failing. The protocol consisted of six increasingly difficult perturbations levels for the backward translations and four increasingly difficult perturbation levels for the toe-up rotational perturbations. Withing each level, eight perturbations were administered. When participants stepped I more than 3 trials within a level, the participant did not continue to the next level.
Trajectories of reflective skin markers were captured by infrared Vicon Cameras and activity of the lower leg muscles (lateral gastrocnemius, medial gastrocnemius, soleus and tibialis anterior) was measured simultaneously through surface electromyography.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Vlaams-Brabant
-
Leuven、Vlaams-Brabant、ベルギー、3000
- UZ Leuven
-
-
参加基準
適格基準
就学可能な年齢
- 子
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
Children with spastic cerebral palsy, who have routine follow-up care at the CP reference center of the university hospitals Leuven.
Typically developing children are recruited through the social and professional network of involved researchers and thesis studies, who approach participants through flyers and social media.
説明
Children with CP:
Inclusion Criteria:
- Diagnosis of cerebral palsy
- Spasticity as defined by clinical assessment
- Aged between 5-17 years old
- Gross motor classification scale I-III
- Able to stand independently for at least 10 minutes
Exclusion Criteria:
- Orthopedic/neurological surgery in the previous year
- Botulinum neurotoxin injections in the past 6 months
- Presence of ataxia or dystonia
- Cognitive problems that impede measurements
- Severe co-morbidities
Typically developing children:
Inclusion criteria:
- Aged between 5 and 17 years old
- Good health
Exclusion criteria:
- Presence of neuro-musculoskeletal or vestibular diseases
- Lower limb injuries during the past 6 months
- Irritated skin or open wounds where sensors will be placed (CP en TD)
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Children with cerebral palsy
Children with CP aged between 5 and 17
|
|
Typically developing children
Typically developing children aged between 5 and 17
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Balance performance
時間枠:Cross-sectional data collection at a single time point (baseline measurement).
|
The number (#) of completed perturbation levels (backward translational and toe-up rotational) without stepping.
|
Cross-sectional data collection at a single time point (baseline measurement).
|
|
Maximal horizontal center of mass displacement
時間枠:Cross-sectional data collection at a single time point (baseline measurement).
|
The maximal horizontal Center of Mass (CoM) displacement (cm) is computed in a period of 1.5s following perturbation onset. CoM position is computed by consequently applying OpenSim's Inverse Kinematics and Body Kinematics tools with reflective marker trajectories as input. CoM displacement was calculated relative to the ankle. |
Cross-sectional data collection at a single time point (baseline measurement).
|
|
Goodness of fit between predicted and reconstructed muscles activity - R²
時間枠:Cross-sectional data collection at a single time point (baseline measurement)
|
Computational model; Sensorimotor transformations were evaluated by reconstructing measured EMG trajectories (V) by delayed feedback from CoM kinematics. EMGrecon=e0+⌊kd∗dCoM(t -τ)+kv∗vCoM(t -τ)+ka∗aCoM(t -τ)+ks ∗aCoM Init(t -τ)⌋ with EMG recon = reconstructed muscle activity E0 = baseline muscle activity (during quiet standing) dCoM, vCoM, aCoM = CoM displacement, velocity and acceleration kd, kv, ka = feedbakc gains or weights τ = common time delay of 100 ms To test whether CoM feedback can explain reactive muscle activity, the goodness of fit was assessed between predicted and reconstructed muscle activity using the coefficient of determination (r²). R² was calculated as the squared correlation coefficient. |
Cross-sectional data collection at a single time point (baseline measurement)
|
|
Goodness of fit between predicted and reconstructed muscles activity - VAF
時間枠:Cross-sectional data collection at a single time point (baseline measurement)
|
Computational model; Sensorimotor transformations were evaluated by reconstructing measured EMG trajectories (V) by delayed feedback from CoM kinematics. EMGrecon=e0+⌊kd∗dCoM(t -τ)+kv∗vCoM(t -τ)+ka∗aCoM(t -τ)+ks ∗aCoM Init(t -τ)⌋ with EMG recon = reconstructed muscle activity E0 = baseline muscle activity (during quiet standing) dCoM, vCoM, aCoM = CoM displacement, velocity and acceleration kd, kv, ka = feedbakc gains or weights τ = common time delay of 100 ms To test whether CoM feedback can explain reactive muscle activity, the goodness of fit was assessed between predicted and reconstructed muscle activity using the Variance Accounted For (VAF). VAF was calculated as the uncentered r² |
Cross-sectional data collection at a single time point (baseline measurement)
|
|
Goodness of fit between predicted and reconstructed muscles activity - RMSE
時間枠:Cross-sectional data collection at a single time point (baseline measurement)
|
Computational model; Sensorimotor transformations were evaluated by reconstructing measured EMG trajectories (V) by delayed feedback from CoM kinematics. EMGrecon=e0+⌊kd∗dCoM(t -τ)+kv∗vCoM(t -τ)+ka∗aCoM(t -τ)+ks ∗aCoM Init(t -τ)⌋ with EMG recon = reconstructed muscle activity E0 = baseline muscle activity (during quiet standing) dCoM, vCoM, aCoM = CoM displacement, velocity and acceleration kd, kv, ka = feedbakc gains or weights τ = common time delay of 100 ms To test whether CoM feedback can explain reactive muscle activity, the goodness of fit was assessed between predicted and reconstructed muscle activity using the Root Mean Square Error (RMSE). |
Cross-sectional data collection at a single time point (baseline measurement)
|
|
Sensitiviy of reactive muscle activity to CoM perturbations - gains
時間枠:Cross-sectional data collection at a single time point (baseline measurement)
|
Computational model; Sensorimotor transformations were evaluated by reconstructing measured EMG trajectories (V) by delayed feedback from CoM kinematics. EMGrecon=e0+⌊kd∗dCoM(t -τ)+kv∗vCoM(t -τ)+ka∗aCoM(t -τ)+ks ∗aCoM Init(t -τ)⌋ with EMG recon = reconstructed muscle activity E0 = baseline muscle activity (during quiet standing) dCoM, vCoM, aCoM = CoM displacement, velocity and acceleration kd, kv, ka = feedbakc gains or weights τ = common time delay of 100 ms To test the sensitivity of the reactive muscle activity to the CoM perurbations, the gains (kd,kv,ka) were assessed. Gains indicate the sensitivity of the muscle response to CoM perturbations. |
Cross-sectional data collection at a single time point (baseline measurement)
|
|
Mean reactive muscle activity
時間枠:Cross-sectional data collection at a single time point (baseline measurement).
|
Average reactive muscle activity for
The first time bin lasted from platform onset to 150 ms after perturbation onset. The second time bin lasted from 150 ms to 250 ms after perturbation onset. The third time bin lasted from 250 ms to 400 ms after perturbation onset. |
Cross-sectional data collection at a single time point (baseline measurement).
|
|
Mean center of mass movement
時間枠:Cross-sectional data collection at a single time point (baseline measurement).
|
Average horizontal center of mass movement (cm) was computed in three time bins. The first time bin lasted from platform onset to 50 ms after perturbation onset. The second time bin lasted from 50 ms to 150 ms after perturbation onset. The third time bin lasted from 150 ms to 300 ms after perturbation onset. |
Cross-sectional data collection at a single time point (baseline measurement).
|
|
Mean ankle kinematics
時間枠:Cross-sectional data collection at a single time point (baseline measurement).
|
Average ankle kinematics (°) was computed in three time bins. The first time bin lasted from platform onset to 50 ms after perturbation onset. The second time bin lasted from 50 ms to 150 ms after perturbation onset. The third time bin lasted from 150 ms to 300 ms after perturbation onset. |
Cross-sectional data collection at a single time point (baseline measurement).
|
|
Co-Contraction Index (CCI) during translational and rotational perturbations and during isolated joint rotations
時間枠:Cross-sectional data collection at a single time point (baseline measurement).
|
The co-contraction index was calculated as the minimum tibialis anterior and respectively lateral gastrocnemius, medial gastrocnemius and soleus filtered and scaled EMG averaged over the time interval of interest. CCI was calculated during backward translational, toe-up rotational perturbations and during isolated joint rotations. |
Cross-sectional data collection at a single time point (baseline measurement).
|
協力者と研究者
協力者
捜査官
- 主任研究者:Kaat Desloovere, Prof. dr.、Department of Rehabilitation Sciences, KU Leuven, Belgium
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- S63321
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。